Singapore, Dec. 9 -- Leading scientific organisations in Korea including the Korea Disease Control Agency (KDCA), International Vaccine Institute (IVI), ST Pharm and Seoul National University (SNU), are joining forces with Norway-basedCoalition for Epidemic Preparedness Innovations (CEPI) to advance a new AI-designed mRNA vaccine that could become the first-ever vaccine to protect against a potentially deadly tick-borne disease affecting countries in Asia.

Cases of severe fever with thrombocytopaenia syndrome, or SFTS-caused by the SFTS virus, also known as Dabie Bandavirus-have been reported in China, Japan, Korea, Taiwan and Vietnam. Countries like Korea have identified SFTS as a significant public health concern and made the developme...